Structures by: Hursthouse M. B.
Total: 1 912
C108H88Cl4O12P4Pd2
C108H88Cl4O12P4Pd2
Chemical Communications (Cambridge, United Kingdom) (2006) 37 3880-3882
a=15.6433(17)Å b=19.522(3)Å c=18.184(2)Å
α=90.00° β=93.354(5)° γ=90.00°
C18H24N2O2
C18H24N2O2
Chemical Communications (Cambridge, United Kingdom) (2006) 28 2983-2985
a=7.6733(6)Å b=13.630(2)Å c=15.8871(19)Å
α=90.00° β=90.00° γ=90.00°
C15H20INO2
C15H20INO2
Chemical Communications (Cambridge, United Kingdom) (2006) 28 2983-2985
a=12.7729(7)Å b=7.4551(4)Å c=17.0731(8)Å
α=90.00° β=107.236(4)° γ=90.00°
C20H5BF10FeO3
C20H5BF10FeO3
Chemical Communications (2006) 24
a=7.4491(3)Å b=8.4985(4)Å c=15.6646(5)Å
α=103.233(2)° β=90.730(2)° γ=92.815(2)°
C20H4BF11FeO3
C20H4BF11FeO3
Chemical Communications (2006) 24
a=7.5733(4)Å b=8.4751(4)Å c=15.5751(7)Å
α=103.050(2)° β=90.431(2)° γ=92.131(2)°
[Ni(TUP)4(H2O)2]SO4.2H2O
C52H58N12NiO12S
Chemical communications (Cambridge, England) (2004) 12 1354-1355
a=18.028(3)Å b=18.028(3)Å c=8.1143(16)Å
α=90.00° β=90.00° γ=90.00°
C52H64CoN12O12S
C52H64CoN12O12S
Chemical communications (Cambridge, England) (2004) 12 1354-1355
a=18.070(3)Å b=18.070(3)Å c=8.0756(16)Å
α=90.00° β=90.00° γ=90.00°
[Zn(TUP)4(H2O)2]SO4.2H2O
C52H60N12O14SZn
Chemical communications (Cambridge, England) (2004) 12 1354-1355
a=18.0760(5)Å b=18.0760(5)Å c=8.1208(3)Å
α=90.00° β=90.00° γ=90.00°
[Cu(TUP)4(H2O)2]SO4.2H2O
C52H56CuN12O12S
Chemical communications (Cambridge, England) (2004) 12 1354-1355
a=17.846(3)Å b=17.846(3)Å c=8.3019(17)Å
α=90.00° β=90.00° γ=90.00°
C40H59N7O2
C40H59N7O2
Chemical communications (Cambridge, England) (2009) 34, 21 3017-3019
a=10.2826(2)Å b=20.5801(6)Å c=35.6410(10)Å
α=90.00° β=90.00° γ=90.00°
C38H51N7,3(C2H6OS)
C38H51N7,3(C2H6OS)
Chemical communications (Cambridge, England) (2009) 34, 21 3017-3019
a=10.4348(2)Å b=22.9357(3)Å c=19.7522(3)Å
α=90.00° β=100.8400(10)° γ=90.00°
C42H63N7O2S2
C42H63N7O2S2
Chemical communications (Cambridge, England) (2009) 34, 21 3017-3019
a=10.5958(3)Å b=11.3296(3)Å c=17.7452(4)Å
α=84.7310(10)° β=89.8080(10)° γ=76.5870(10)°
C44H63N5O3
C44H63N5O3
Chemical communications (Cambridge, England) (2008) 26 3007-3009
a=8.5824(3)Å b=19.9254(9)Å c=24.1820(10)Å
α=90.00° β=95.659(3)° γ=90.00°
C66H92F6O3PPdS3Sb
C66H92F6O3PPdS3Sb
Chemical communications (Cambridge, England) (2008) 21 2429-2431
a=12.32(2)Å b=12.719(13)Å c=22.10(5)Å
α=83.91(11)° β=79.8(2)° γ=78.56(8)°
C42H62Cl2O3PPd,C48H74O3PPdS3,C2D3N
C42H62Cl2O3PPd,C48H74O3PPdS3,C2D3N
Chemical communications (Cambridge, England) (2008) 21 2429-2431
a=15.297(4)Å b=18.455(4)Å c=19.724(7)Å
α=108.554(19)° β=107.430(19)° γ=98.853(15)°
C22H24N2O20Zn5
C22H24N2O20Zn5
Chemical communications (Cambridge, England) (2008) 43 5538-5540
a=9.1586(4)Å b=9.7969(4)Å c=9.8730(5)Å
α=77.598(2)° β=89.947(3)° γ=88.060(3)°
C24H22N2O10Zn2
C24H22N2O10Zn2
Chemical communications (Cambridge, England) (2008) 43 5538-5540
a=8.7651(3)Å b=8.7941(4)Å c=13.6911(6)Å
α=73.567(2)° β=73.048(2)° γ=81.472(2)°
C22H18N2O10Zn2,4C3H7NO
C22H18N2O10Zn2,4C3H7NO
Chemical communications (Cambridge, England) (2008) 43 5538-5540
a=8.7994(6)Å b=53.888(3)Å c=8.8039(6)Å
α=90.00° β=90.111(2)° γ=90.00°
C15H16N2O3
C15H16N2O3
CrystEngComm (2006) 8, 6 448
a=10.1051(6)Å b=28.8085(18)Å c=4.8380(2)Å
α=90.00° β=103.868(10)° γ=90.00°
C13H20B10O2
C13H20B10O2
CrystEngComm (2010) 12, 12 4109
a=20.7860(2)Å b=20.7860(2)Å c=32.3848(7)Å
α=90.00° β=90.00° γ=90.00°
C18H24B10O
C18H24B10O
CrystEngComm (2010) 12, 12 4109
a=19.1234(8)Å b=9.0888(4)Å c=23.1603(7)Å
α=90.00° β=95.767(2)° γ=90.00°
C9H19B10NO
C9H19B10NO
CrystEngComm (2010) 12, 12 4109
a=13.8781(6)Å b=14.4748(4)Å c=14.8852(7)Å
α=90.00° β=90.00° γ=90.00°
C17H24B10O
C17H24B10O
CrystEngComm (2010) 12, 12 4109
a=17.6653(3)Å b=17.6653(3)Å c=12.7609(3)Å
α=90.00° β=90.00° γ=90.00°
C6CrNaO12,3(C10H8S8),C2H6O
C6CrNaO12,3(C10H8S8),C2H6O
CrystEngComm (2015) 17, 14 2783
a=8.8372(2)Å b=9.5138(2)Å c=18.1928(4)Å
α=81.9380(10)° β=77.4830(10)° γ=68.0910(10)°
C6CrNaO12,3(C10H8S8),C2H3N
C6CrNaO12,3(C10H8S8),C2H3N
CrystEngComm (2015) 17, 14 2783
a=10.4088(4)Å b=14.7524(8)Å c=18.2275(8)Å
α=90° β=94.741(3)° γ=90°
C10H8S8,C2O4,0.33(CrNa),0.33(C3H7NO)
C10H8S8,C2O4,0.33(CrNa),0.33(C3H7NO)
CrystEngComm (2015) 17, 14 2783
a=5.3536(5)Å b=10.1811(9)Å c=17.2836(15)Å
α=95.641(4)° β=97.596(5)° γ=90.246(6)°
C5H10N3O4P
C5H10N3O4P
CrystEngComm (2014) 16, 11 2205
a=14.6204(10)Å b=7.6631(4)Å c=16.002(2)Å
α=90.00° β=97.234(9)° γ=90.00°
4-aminopyridinium_hydrogenosulfate
C5H7N2,HO4S
CrystEngComm (2014) 16, 11 2205
a=10.9507(4)Å b=6.4615(2)Å c=11.2614(3)Å
α=90.00° β=102.988(2)° γ=90.00°
C5H7N3O3
C5H7N3O3
CrystEngComm (2014) 16, 11 2205
a=9.1718(6)Å b=6.9081(4)Å c=10.8243(7)Å
α=90.00° β=93.617(7)° γ=90.00°
C10H16N4O5S
C10H16N4O5S
CrystEngComm (2014) 16, 11 2205
a=6.4515(2)Å b=8.4229(2)Å c=12.4728(8)Å
α=96.429(7)° β=97.523(7)° γ=95.349(7)°
C5H8N4O3
C5H8N4O3
CrystEngComm (2014) 16, 11 2205
a=7.0735(5)Å b=11.0546(8)Å c=9.4018(6)Å
α=90.00° β=92.308(7)° γ=90.00°
Bis(3,4-diaminopyridinium)_sulfate_dihydrate
2(C5H8N3),O4S,2(H2O)
CrystEngComm (2014) 16, 11 2205
a=15.2902(10)Å b=15.2902(10)Å c=13.2563(7)Å
α=90.00° β=90.00° γ=90.00°
3,4-diaminopyridinium_sulfate_dihydrate
C5H9N3,O4S,2(H2O)
CrystEngComm (2014) 16, 11 2205
a=6.9429(3)Å b=10.2338(5)Å c=14.5568(8)Å
α=103.319(2)° β=100.970(3)° γ=92.592(3)°
C5H11N2O5P
C5H11N2O5P
CrystEngComm (2014) 16, 11 2205
a=7.2785(4)Å b=7.9141(4)Å c=8.9022(6)Å
α=77.651(6)° β=71.756(5)° γ=67.405(5)°
C20H21F2NO3
C20H21F2NO3
Journal of the Chemical Society, Perkin Transactions 1 (1999) 17 2525
a=7.7023(13)Å b=9.925(2)Å c=13.356(2)Å
α=80.96(3)° β=76.495(11)° γ=70.767(13)°
C17H22F2N2O6
C17H22F2N2O6
Journal of the Chemical Society, Perkin Transactions 1 (1999) 17 2525
a=7.7241(3)Å b=25.4363(8)Å c=10.1058(4)Å
α=90.00° β=103.0745(16)° γ=90.00°
C23H28N4O4S2
C23H28N4O4S2
Journal of the Chemical Society, Perkin Transactions 1 (1999) 17 2483
a=8.9200(10)Å b=9.8450(10)Å c=26.8780(10)Å
α=90° β=92.23(2)° γ=90°
C17H18N2O
C17H18N2O
Journal of the Chemical Society, Perkin Transactions 1 (2000) 15 2331
a=8.831(2)Å b=11.534(2)Å c=13.182(3)Å
α=90.34(3)° β=92.49(3)° γ=90.79(3)°
C16H16N2O3
C16H16N2O3
Journal of the Chemical Society, Perkin Transactions 1 (2000) 15 2331
a=7.1760(10)Å b=17.805(4)Å c=20.947(4)Å
α=90.00° β=90.00° γ=90.00°
C25H28N2O4
C25H28N2O4
Journal of the Chemical Society, Perkin Transactions 1 (2000) 15 2331
a=11.0117(5)Å b=10.6661(8)Å c=12.2753(9)Å
α=65.331(3)° β=65.329(4)° γ=62.908(3)°
C21H16Cl2O2S2
C21H16Cl2O2S2
Journal of the Chemical Society, Perkin Transactions 1 (2000) 17 2930
a=6.977(10)Å b=40.172(17)Å c=7.607(14)Å
α=90.00° β=115.05(9)° γ=90.00°
C10H8N4O2
C10H8N4O2
Journal of the Chemical Society, Perkin Transactions 2 (2000) 11 2280
a=6.231(2)Å b=8.198(3)Å c=10.300(4)Å
α=99.17(3)° β=95.29(4)° γ=106.630(16)°
C18H18N6O4
C18H18N6O4
Journal of the Chemical Society, Perkin Transactions 1 (2001) 24 3365-3381
a=6.7111(2)Å b=9.2637(5)Å c=15.5593(8)Å
α=103.438(2)° β=98.437(3)° γ=102.274(3)°
C19H20F3N5O6
C19H20F3N5O6
Journal of the Chemical Society, Perkin Transactions 1 (2001) 24 3365-3381
a=13.8726(9)Å b=30.229(3)Å c=9.8793(6)Å
α=90.00° β=90.00° γ=90.00°
C23H32N6O2S
C23H32N6O2S
Journal of the Chemical Society, Perkin Transactions 1 (2001) 11 1258
a=9.4566(3)Å b=10.7149(4)Å c=13.2326(4)Å
α=89.975(2)° β=79.123(2)° γ=65.1932(12)°
3-methoxyaspirin
C10H10O5
CrystEngComm (2011) 13, 10 3390
a=9.5451(3)Å b=14.2427(5)Å c=7.3811(2)Å
α=90.00° β=102.716(2)° γ=90.00°
4-methoxyaspirin
C10H10O5
CrystEngComm (2011) 13, 10 3390
a=5.06880(10)Å b=9.4619(3)Å c=20.0281(6)Å
α=90.00° β=94.069(2)° γ=90.00°
5-methoxyaspirin
C10H10O5
CrystEngComm (2011) 13, 10 3390
a=5.03850(10)Å b=17.3609(5)Å c=10.8931(3)Å
α=90.00° β=95.402(2)° γ=90.00°
6-fluoroaspirin
C9H7FO4
CrystEngComm (2011) 13, 10 3390
a=7.3711(2)Å b=7.09520(10)Å c=16.7141(4)Å
α=90.00° β=100.9190(10)° γ=90.00°
C25H17N3O2
C25H17N3O2
Journal of the Chemical Society, Perkin Transactions 1 (2001) 7 680
a=15.508(2)Å b=3.832(4)Å c=30.909(2)Å
α=90.00° β=92.30(3)° γ=90.00°
C20H15N3
C20H15N3
Journal of the Chemical Society, Perkin Transactions 1 (2001) 7 680
a=25.908(5)Å b=10.067(2)Å c=11.851(2)Å
α=90.00° β=103.36(3)° γ=90.00°
C40H30N2
C40H30N2
Journal of the Chemical Society, Perkin Transactions 1 (2001) 21 2781
a=10.257(2)Å b=28.375(5)Å c=10.590(2)Å
α=90.00° β=112.21(3)° γ=90.00°
4-aminopyridinium_6-fluorosalicylate
C7H4FO3,C5H7N2
CrystEngComm (2012) 14, 21 7466
a=11.655(1)Å b=11.6654(3)Å c=16.9859(4)Å
α=90.00° β=90.00° γ=90.00°
4-aminopyridium_5-bromosalicylate_monohydrate
C7H4BrO3,C5H7N2,H2O
CrystEngComm (2012) 14, 21 7466
a=17.1666(5)Å b=3.85010(10)Å c=19.5610(4)Å
α=90.00° β=90.00° γ=90.00°
4-aminopyridinium 5-iodosalicylate monohydrate
C7H4IO3,C5H7N2,H2O
CrystEngComm (2012) 14, 21 7466
a=4.400(5)Å b=18.068(5)Å c=8.581(5)Å
α=90.00° β=96.077(5)° γ=90.00°
4-aminopyridinium_5-acetylaminosalicylate
C9H8NO4,C5H7N2
CrystEngComm (2012) 14, 21 7466
a=15.1705(7)Å b=4.6669(2)Å c=19.6506(8)Å
α=90.00° β=104.734(2)° γ=90.00°
4-aminopyridium_5-aminosalicylate_pyridine
C7H6NO3,C5H7N2,C5H5N
CrystEngComm (2012) 14, 21 7466
a=23.3169(11)Å b=8.1015(4)Å c=18.0588(8)Å
α=90.00° β=110.986(2)° γ=90.00°
4-aminopyridinium_5-chlorosalicylate
C7H4ClO3,C5H7N2
CrystEngComm (2012) 14, 21 7466
a=11.9815(5)Å b=7.9626(2)Å c=12.4836(5)Å
α=90.00° β=100.400(2)° γ=90.00°
4-aminopyridinium_5-chlorosalicylate_hydrate
C7H4ClO3,C5H7N2,H2O
CrystEngComm (2012) 14, 21 7466
a=4.4573(5)Å b=17.317(2)Å c=8.4840(7)Å
α=90.00° β=97.333(7)° γ=90.00°
4-aminopyridinium_5-fluorosalicylate
C7H4FO3,C5H7N2
CrystEngComm (2012) 14, 21 7466
a=10.7838(4)Å b=8.5407(2)Å c=12.1504(5)Å
α=90.00° β=95.099(2)° γ=90.00°
4-aminopyridinium_5-iodosalicylate
C7H4IO3,C5H7N2
CrystEngComm (2012) 14, 21 7466
a=13.6431(3)Å b=8.1006(2)Å c=12.4428(2)Å
α=90.00° β=112.2790(10)° γ=90.00°
4-aminopyridium_5-iodosalicylate_pyridine
C7H4IO3,C5H7N2,C5H5N
CrystEngComm (2012) 14, 21 7466
a=18.6570(10)Å b=8.6657(5)Å c=10.9293(5)Å
α=90.00° β=102.573(4)° γ=90.00°
4-aminopyridinium_5-methoxysalicylate_monohydrate
C8H7O4,C5H7N2,H2O
CrystEngComm (2012) 14, 21 7466
a=21.8619(15)Å b=15.0658(9)Å c=3.9918(3)Å
α=90.00° β=90.00° γ=90.00°
4-aminopyridinium_5-methylsalicylate
C8H7O3,C5H7N2
CrystEngComm (2012) 14, 21 7466
a=13.5414(3)Å b=15.0598(2)Å c=13.0106(2)Å
α=90.00° β=108.6450(10)° γ=90.00°
4-aminopyridinium 5-nitrosalicylate
C7H4NO5,C5H7N2
CrystEngComm (2012) 14, 21 7466
a=3.77770(10)Å b=12.5991(5)Å c=25.0825(10)Å
α=90.00° β=90.00° γ=90.00°
C48H64N8
C48H64N8
CrystEngComm (2010) 12, 4 1048
a=31.7084(16)Å b=5.6724(2)Å c=22.6344(11)Å
α=90.00° β=134.288(5)° γ=90.00°
C22H12S3
C22H12S3
Journal of Materials Chemistry (2010) 20, 6 1112
a=15.8475(14)Å b=15.8514(14)Å c=6.9724(4)Å
α=90.00° β=98.498(6)° γ=90.00°
2-acetyloxy-4-methylbenzoic acid
C10H10O4
CrystEngComm (2010) 12, 3 953
a=4.6363(3)Å b=10.3293(9)Å c=19.5855(16)Å
α=90.00° β=93.632(5)° γ=90.00°
2-acetyloxy-5-bromobenzoic acid
C9H7BrO4
CrystEngComm (2010) 12, 3 953
a=10.3912(4)Å b=4.72650(10)Å c=19.5116(9)Å
α=90.00° β=96.383(2)° γ=90.00°
2-acetyloxy-5-chlorobenzoic acid
C9H7ClO4
CrystEngComm (2010) 12, 3 953
a=10.1217(4)Å b=4.73590(10)Å c=19.4447(7)Å
α=90.00° β=96.219(2)° γ=90.00°
2-acetyloxy-5-iodobenzoic acid
C9H7IO4
CrystEngComm (2010) 12, 3 953
a=10.7838(5)Å b=4.7168(2)Å c=19.5502(8)Å
α=90.00° β=96.630(2)° γ=90.00°
2-acetyloxy-5-methylbenzoic acid
C10H10O4
CrystEngComm (2010) 12, 3 953
a=10.1301(3)Å b=4.88310(10)Å c=18.9682(7)Å
α=90.00° β=100.696(2)° γ=90.00°
2-acetyloxy-5-nitrobenzoic acid
C9H7NO6
CrystEngComm (2010) 12, 3 953
a=9.9166(3)Å b=5.04440(10)Å c=18.6808(5)Å
α=90.00° β=99.6860(10)° γ=90.00°
Suberic acid & imidazole
C30H50N4O12
CrystEngComm (2010) 12, 3 898
a=8.7148(3)Å b=11.4826(3)Å c=16.9691(5)Å
α=81.721(2)° β=81.814(2)° γ=77.987(2)°
Glutaric Acid and 1-Methylimidazole
C18H28N4O8
CrystEngComm (2010) 12, 3 898
a=8.1285(6)Å b=9.1297(7)Å c=13.7387(11)Å
α=89.781(4)° β=89.170(4)° γ=79.782(5)°
Succinic acid & 4-methylimidazole
C8H12N2O4
CrystEngComm (2010) 12, 3 898
a=3.9015(2)Å b=17.3293(10)Å c=13.8628(7)Å
α=90.00° β=96.299(3)° γ=90.00°
Glutaric acid & 2-methylimidazole
C9H14N2O4
CrystEngComm (2010) 12, 3 898
a=5.3800(3)Å b=8.1542(6)Å c=12.6592(10)Å
α=78.350(4)° β=82.962(4)° γ=84.496(4)°
Adipic Acid and 2-Methylimidazole
C10H18N2O5
CrystEngComm (2010) 12, 3 898
a=4.8629(3)Å b=7.9978(5)Å c=16.5263(11)Å
α=96.9510(10)° β=94.4750(10)° γ=107.3840(10)°
Succinic Acid and 2-Methylimidazole
C8H12N2O4
CrystEngComm (2010) 12, 3 898
a=8.1472(7)Å b=6.4965(5)Å c=9.0107(5)Å
α=90.00° β=97.401(4)° γ=90.00°
Fumaric acid & 2-methylimidazole
C8H10N2O4
CrystEngComm (2010) 12, 3 898
a=8.0829(5)Å b=6.2852(4)Å c=9.0979(6)Å
α=90.00° β=97.551(4)° γ=90.00°
Suberic acid & 2-methylimidazole
C12H20N2O4
CrystEngComm (2010) 12, 3 898
a=7.3683(4)Å b=9.0497(3)Å c=10.7486(5)Å
α=76.546(3)° β=80.396(2)° γ=76.933(3)°
Fumaric acid and 1,2-dimethylimidazole
C9H12N2O4
CrystEngComm (2010) 12, 3 898
a=7.6480(7)Å b=11.6730(9)Å c=11.2040(11)Å
α=90.00° β=93.547(4)° γ=90.00°
Glutaric acid & 1,2-dimethylimidazole
C10H16N2O4
CrystEngComm (2010) 12, 3 898
a=10.4056(16)Å b=22.888(4)Å c=4.6392(9)Å
α=90.00° β=90.00° γ=90.00°
Succinic acid & 1,2-dimethylimidazole
C9H14N2O4
CrystEngComm (2010) 12, 3 898
a=20.5769(12)Å b=7.3521(4)Å c=14.0383(8)Å
α=90.00° β=90.00° γ=90.00°
Glutaric Acid & 4-Methylimidazole
C9H14N2O4
CrystEngComm (2010) 12, 3 898
a=7.5360(4)Å b=14.2180(8)Å c=9.7160(6)Å
α=90.00° β=96.571(3)° γ=90.00°
Oxalic acid & 4-methylimidazole hydrate
C10H16N4O5
CrystEngComm (2010) 12, 3 898
a=9.1937(6)Å b=13.5734(6)Å c=10.5047(5)Å
α=90.00° β=99.252(4)° γ=90.00°
Oxalic acid & 2-methylimidazole
C10H14N4O4
CrystEngComm (2010) 12, 3 898
a=13.3293(19)Å b=13.1137(16)Å c=14.023(2)Å
α=90.00° β=90.00° γ=90.00°
Malonic acid & imidazole
C15H20N6O8
CrystEngComm (2010) 12, 3 898
a=6.9980(3)Å b=8.3790(3)Å c=9.2500(3)Å
α=116.302(2)° β=101.825(2)° γ=91.149(2)°
Malonic Acid and 2-Methylimidazole
C7H10N2O4
CrystEngComm (2010) 12, 3 898
a=11.4966(19)Å b=18.702(3)Å c=3.9535(5)Å
α=90.00° β=90.00° γ=90.00°
Maleic Acid & 4-Methylimidazole
C8H10N2O4
CrystEngComm (2010) 12, 3 898
a=5.5883(2)Å b=22.5838(12)Å c=7.3581(4)Å
α=90.00° β=98.578(3)° γ=90.00°
C21H36Cl3OPPd
C21H36Cl3OPPd
Dalton Transactions (2003) 21 4164
a=10.63170(10)Å b=22.1407(3)Å c=11.3297(2)Å
α=90.00° β=112.61° γ=90.00°
CrLi3(C2O4),3(C10H8S8),(C2H6O)
CrLi3(C2O4),3(C10H8S8),(C2H6O)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 13 6219-6223
a=18.1981Å b=14.9510Å c=10.1086Å
α=90.0000° β=93.1270° γ=90.0000°
C6H2FeLiO13,4(C10H8S8)
C6H2FeLiO13,4(C10H8S8)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 13 6219-6223
a=8.7086(5)Å b=37.248(2)Å c=22.1051(14)Å
α=90° β=90.193(3)° γ=90°
FeLi3(C2O4),3(C10H8S8),(C2H6O)
FeLi3(C2O4),3(C10H8S8),(C2H6O)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 13 6219-6223
a=18.491(11)Å b=15.146(9)Å c=10.292(6)Å
α=90.0000° β=93.363(16)° γ=90.0000°
C54H39Au2Cl4F6OP2
C54H39Au2Cl4F6OP2
Crystal Structure Report Archive (2008) 601
a=12.17660(10)Å b=14.4577(2)Å c=15.1547(2)Å
α=76.8180(10)° β=79.6220(10)° γ=73.5100(10)°
N,N'-bis(3-Methoxyphenyl)urea
C15H16N2O3
Crystal Structure Report Archive (2008) 684
a=10.0265(3)Å b=4.5597(2)Å c=29.0659(11)Å
α=90.00° β=90.00° γ=90.00°
C5H10Cl4N3O2P3
C5H10Cl4N3O2P3
Crystal Structure Report Archive (2008) 483
a=11.5390(9)Å b=12.4271(8)Å c=9.9748(5)Å
α=90.00° β=90.00° γ=90.00°
Malonic Acid and 2-Methylimidazole
C7H10N2O4
Crystal Structure Report Archive (2008) 515
a=11.4966(19)Å b=18.702(3)Å c=3.9535(5)Å
α=90.00° β=90.00° γ=90.00°
C10H10FeI3
C10H10FeI3
Crystal Structure Report Archive (2001) 831
a=8.4610(6)Å b=8.4610(6)Å c=16.9880(6)Å
α=90.00° β=90.00° γ=120.00°
C47H54Cl2IrN2O3P
C47H54Cl2IrN2O3P
Crystal Structure Report Archive (2001) 723
a=10.4777(4)Å b=10.9221(3)Å c=19.7314(8)Å
α=97.1510(16)° β=92.3640(15)° γ=97.7630(15)°